Wedbush Reiterates “Outperform” Rating for Generation Bio (NASDAQ:GBIO)
Generation Bio (NASDAQ:GBIO – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at Wedbush in a research report issued on Thursday,RTT News reports. They currently have a $5.00 price target on the stock. Wedbush’s price target suggests a potential upside of 110.08% from the company’s current price. Separately, Needham & Company […]
More Stories
Newmark Group (NASDAQ:NMRK) Issues Quarterly Earnings Results
Newmark Group (NASDAQ:NMRK – Get Free Report) issued its earnings results on Tuesday. The company reported $0.33 earnings per share...
Trump Announces Susan Wiles as White House Chief of Staff
By Tom Ozimek President-elect Donald Trump has announced that Susan Wiles, his 2024 presidential campaign manager, will serve as White...
Peoples (OTCMKTS:PPLL) Trading Down 0.4% – What’s Next?
Peoples Ltd. (OTCMKTS:PPLL – Get Free Report) shares were down 0.4% during trading on Tuesday . The company traded as...
CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Down 2% – Here’s What Happened
CompuGroup Medical SE & Co. KGaA (ETR:COP – Get Free Report)’s stock price fell 2% during mid-day trading on Tuesday...
iShares Currency Hedged MSCI EAFE Small-Cap ETF (NYSEARCA:HSCZ) Trading 0.5% Higher – Still a Buy?
iShares Currency Hedged MSCI EAFE Small-Cap ETF (NYSEARCA:HSCZ – Get Free Report)’s stock price shot up 0.5% during trading on...
Ceapro (CVE:CZO) Stock Price Down 11.8% – Here’s What Happened
Ceapro Inc. (CVE:CZO – Get Free Report) fell 11.8% on Tuesday . The company traded as low as C$0.23 and...